Narrowed from a review of more than 20,000 US issued patents covering stem cell related matter, Regen BioPharma us in negotiations to license several patents for cell therapy products...
Regen BioPharma, Inc., is a wholly owned
subsidiary of Bio-Matrix Scientific Group, Inc.
(OTCQB: BMSN) (PINKSHEETS: BMSN). Click
below to access SEC regulatory filings.
SAN DIEGO, CA--(Marketwire - Apr 30, 2012) -
Bio-Matrix Scientific Group, Inc. announced
today that it's subsidiary, Regen BioPharma,
Inc. secured $20,000,000 in funding.